Crategus

Krategus: Russian cardiotonic without cardiac glycosides

Krategus is a pharmacological agent belonging to the group of cardiotonics, produced in Russia. It is known for its positive effects on the cardiovascular system and is widely used in medical practice.

The country of origin of Krategus is Russia, and the main manufacturer of this drug is the Bryntsalov-A company. Cratagus is available in tincture dosage form, which is the most common and convenient to use.

The main active ingredient in Krategus is a cardiotonic component obtained from plants. A distinctive feature of this product is the absence of cardiac glycosides, which makes it safer to use and reduces the risk of side effects.

Cratagus has a positive effect on cardiac activity, improves the contractility of the heart muscle and helps normalize heart rhythm. Additionally, it has antioxidant properties that help protect the heart from oxidative stress and related damage.

The use of Krategus is recommended for the treatment of various cardiovascular diseases, such as chronic heart failure, heart rhythm disorders, coronary heart disease and others. It can be prescribed either as the main drug or in combination with other drugs.

Cratagus is usually well tolerated by patients and has few side effects. However, before starting to take this drug, you should consult your doctor and read the instructions to avoid possible contraindications or interactions with other medications.

In conclusion, Krategus is an effective Russian cardiotonic without cardiac glycosides. It has a positive effect on the cardiovascular system, has antioxidant properties and is widely used to treat various heart diseases. However, you should consult your doctor before using it.